Chief Executive Officer
Sol is an inventor and entrepreneur with 20 years experience in medical imaging research and development. He is also an Associate Professor of Engineering at Dartmouth where he is a Member of the Translational Engineering in Cancer Research Program at the Dartmouth-Hitchcock Medical Center. Sol has over 50 publications, 2500 citations, and holds 8 US patents.
Chief Operating Officer
Christian is a biomedical engineer and co-inventor of Lodestone’s IRIS biosensor. He completed his PhD at the Physikalisch-Technische Bundesanstalt in Berlin, Germany focusing on the topic of quantitative detection of magnetic nanoparticles in biological samples. Christian also developed all the mechanical systems for Lodestone’s magnetic readers.
Biomedical Engineer
Lisa is a biomedical engineer with experience in patent examination through past work at the United States Patent and Trademark Office in the field of innovative surgical tools and devices used in orthopedic surgeries. She has also worked extensively with various bioassays in the life sciences industry, as well as in the academic research setting where she focused on using quantum dots to detect single-cell protein secretions.
Mechanical Engineer
Seth is a mechanical engineer with a background in mechanical design of heat exchangers and piping. He completed his Master of Engineering degree at the Thayer School of Engineering at Dartmouth. Seth focuses on the development of Lodestone's magnetic nanoparticle reader platforms and is currently developing the next generation of our preclinical system.
Senior Chemist
Hye Jung is an experienced chemist, who specializes in organic and polymer synthesis, analytical chemistry, and developing biomaterials. Her skills also include developing new products for biomedical applications. She excels in innovative process and product development, where Hye Jung leverages her knowledge of chemistry and biomaterials science. At Lodestone Hye Jung is responsible for the surface functionalization of magnetic nanoparticles with monoclonal antibodies.
Biomedical Engineer
Carmen is a dedicated research technician with extensive experience in pre- and postoperative care for model mice, anesthesia administration, as well as implantation and injection. At Lodestone he is in charge of implant design, miniaturization, and optimization. Currently Carmen designs an automated probe filling station for sterile assembly of Lodestone's implantable biosensor.
Strategic Advisor
John is the CFO and co-founder of S1 Biopharma, a developer of prescription therapeutics for under-treated CNS dysfunctions. Prior to that, John was a finance executive at Laureate Education and Fidelity Investments, where he had senior finance and FP&A roles overseeing multinational high-growth operating subsidiaries.
Research Advisor
Arti is an Assistant Professor of Neurology at Geisel School of Medicine at Dartmouth and the Study Chair and PI on a multi-institutional clinical trial at the Norris Cotton Cancer Center (NCCC) on cancer biomarkers. She is a subject matter expert in cancer biology and immunology and collaborator on Lodestone’s pending grant applications.
Strategic Advisor
Rick is an entrepreneur and biomedical engineer with over 25 years of medical device commercialization experience. He is the founder and CEO of Simbex (Lebanon, NH), and was founding CEO of venture-funded iWalk (now BionX). He is a Fellow of the National Academy of Inventors, and holds 15 US patents, with 4 pending.
Human Resources Advisor
Throughout his forty-five-year career,Roland has developed a strong reputation as an internationally-respected Talent Development expert. He has led Human Resources globally in multiple sectors for global companies of varying complexity, and has successfully coached CEOs, Presidents, General Managers, and other business leaders from twenty countries.
In 2015 Sol Diamond, Lidia Valdés and Brad Ficko set out to revolutionize medical diagnostics and founded Lodestone Biomedical out of a basement laboratory at Dartmouth College. Early on Lodestone aimed to bring low-cost, high-sensitivity magnetic detection methods into the medical device market. Our goal was not to incrementally improve existing diagnostics, but to measure what was previously impossible to detect.In close collaboration with advisors and clinical collaborators, we refined our magnetic detection methods over the years to the cytokine monitoring system we offer today.
A naturally occurring magnetic rock composed of the mineral magnetite.
In ancient times, explorers used lodestones to make magnetic compasses for navigation on land and at sea. This extraordinary history of magnetite is reflected in the name "Lodestone", which means "leading stone.”
Today magnetite forms the core of Lodestone Biomedical's magnetic nanoparticle platform technology for in vivo biomarker monitoring in immuno-oncology. Our biosensors serve as a "molecular compass" for cancer immunotherapy drug development from bench to bedside.
Learn more about the history of the magnetic mineral on the website of the National High Magnetic Field Laboratory.
Leverage our development services for customized in vivo assays and accelerate your pre-clinical research.
Request a Free Consultation
